Elon Musk’s Neuralink implants first brain chip in UK patient

Published 27/10/2025, 18:02
© Reuters.

Investing.com -- Elon Musk’s brain chip startup Neuralink has successfully implanted its device in its first UK participant, a paralyzed man identified as Paul who suffers from motor neuron disease.

The procedure took place at University College London Hospitals earlier this month, according to an announcement from Neuralink on its X social media account. Within hours after surgery, Paul was able to control a computer using only his thoughts.

Neuralink reported that Paul is now collaborating with the company’s engineers to explore additional applications for the implant, including playing his favorite video games such as Dawn of War and performing other tasks that could enhance his daily autonomy.

The UK implant represents a significant expansion of Neuralink’s human trials. Founded by Musk in 2016, the neurotechnology company specializes in developing fully implantable brain-computer interfaces designed to assist people with paralysis.

Neuralink’s main device, known as "the Link," contains a small neural chip with 64 thin threads that can detect brain signals, allowing users to control digital devices through thought alone.

As of Monday, a total of 13 humans have received Neuralink brain implants and are actively participating in the company’s ongoing trials.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.